ZA200705213B - Nanoparticulate tacrolimus formulations - Google Patents
Nanoparticulate tacrolimus formulationsInfo
- Publication number
- ZA200705213B ZA200705213B ZA200705213A ZA200705213A ZA200705213B ZA 200705213 B ZA200705213 B ZA 200705213B ZA 200705213 A ZA200705213 A ZA 200705213A ZA 200705213 A ZA200705213 A ZA 200705213A ZA 200705213 B ZA200705213 B ZA 200705213B
- Authority
- ZA
- South Africa
- Prior art keywords
- nanoparticulate tacrolimus
- tacrolimus formulations
- formulations
- nanoparticulate
- tacrolimus
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63681704P | 2004-12-15 | 2004-12-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200705213B true ZA200705213B (en) | 2009-08-26 |
Family
ID=39129770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200705213A ZA200705213B (en) | 2004-12-15 | 2007-06-29 | Nanoparticulate tacrolimus formulations |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101132768A (en) |
ZA (1) | ZA200705213B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2757979A1 (en) * | 2009-04-09 | 2010-10-14 | Alkermes Pharma Ireland Limited | Controlled-release clozapine compositions |
CN107823214A (en) * | 2017-10-18 | 2018-03-23 | 江苏知原药业有限公司 | Treat the composition of Immunoinflammatory Disorders |
CN112121173B (en) * | 2020-08-22 | 2022-05-06 | 浙江大学 | Fatty acid modified immunosuppressant MMF and FK506 nano preparation and preparation method and application thereof |
CN113425716A (en) * | 2021-05-27 | 2021-09-24 | 南京诺亚药业有限公司 | Tacrolimus pharmaceutical composition and preparation method thereof |
CN116407499A (en) * | 2021-12-29 | 2023-07-11 | 辅必成(上海)医药科技有限公司 | Tacrolimus ophthalmic emulsion and preparation method thereof |
-
2005
- 2005-12-15 CN CNA2005800478949A patent/CN101132768A/en active Pending
-
2007
- 2007-06-29 ZA ZA200705213A patent/ZA200705213B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101132768A (en) | 2008-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL183945A0 (en) | Nanoparticulate tacrolimus formulations | |
IL183549A0 (en) | Nanoparticulate benzothiophene formulations | |
ZA200710113B (en) | Nanoparticulate clopidogrel formulations | |
IL183196A0 (en) | Injectable nanoparticulate olanzapine formulations | |
IL184238A0 (en) | Nanoparticulate candesartan formulations | |
IL181265A0 (en) | Stabilizing formulations | |
ZA200708702B (en) | Nanoparticulate quinazoline derivative formulations | |
EP1738806A4 (en) | Ball | |
GB0423565D0 (en) | Formulation | |
GB0412530D0 (en) | Formulation | |
ZA200705213B (en) | Nanoparticulate tacrolimus formulations | |
HK1076761A1 (en) | Takraw balls | |
ZA200704086B (en) | Antiinfective lipopeptides | |
IL183109A0 (en) | Antiinfective lipopeptides | |
GB0406048D0 (en) | Drug formulations | |
GB0506035D0 (en) | Improved formulation | |
ZA200606977B (en) | Alkaloid formulations | |
GB0402076D0 (en) | Travel ease | |
AP2006003734A0 (en) | Inhalation formulation | |
GB0417226D0 (en) | Formulations | |
IL179208A0 (en) | Intereferon formulations | |
GB0417248D0 (en) | Formulations | |
GB0414443D0 (en) | Castor | |
GB0401070D0 (en) | Castor | |
HRP20040538A2 (en) | Vitalisation ball |